Trials / Not Yet Recruiting
Not Yet RecruitingNCT07025031
Fetal Growth Restriction a Case Control Study
Maternal Serum Progesterone And Placental Heme Oxgenase-1 Expression In Early Onset Idiopathic Fetal Growth Restriction: A Case Control Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (estimated)
- Sponsor
- National University of Malaysia · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The study aims to investigate the responsible factors that leads to idiopathic fetal growth restriction.
Detailed description
The study aims to investigate the relationship between maternal serum level of progesterone, immune-expression of HMOX-1 a placental angiogenesis marker with idiopathic fetal growth restriction.
Conditions
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2025-06-17
- Last updated
- 2025-06-26
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT07025031. Inclusion in this directory is not an endorsement.